Jazz Pharmaceuticals
JAZZ
#1946
Rank
S$12.93 B
Marketcap
S$212.95
Share price
-0.05%
Change (1 day)
31.52%
Change (1 year)

Jazz Pharmaceuticals (JAZZ) - Total debt

Total debt on the balance sheet as of September 2025 : S$7.01 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's total debt is S$7.01 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Jazz Pharmaceuticals - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$8.37 B9.51%
2023-12-31S$7.64 B-1.83%
2022-12-31S$7.79 B-6.33%
2021-12-31S$8.31 B179.53%
2020-12-31S$2.97 B24.62%
2019-12-31S$2.38 B9.49%
2018-12-31S$2.18 B3.14%
2017-12-31S$2.11 B-28.01%
2016-12-31S$2.93 B74.74%
2015-12-31S$1.68 B-5.23%
2014-12-31S$1.77 B154.56%
2013-12-31S$0.69 B24.75%
2012-12-31S$0.55 B
2010-12-31S$61.88 M-64.53%
2009-12-31S$0.17 B-0.34%
2008-12-31S$0.17 B54.82%
2007-12-31S$0.11 B-3.58%
2006-12-31S$0.11 B-4.35%
2005-12-31S$0.12 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Endo International
ENDPQ
S$6.57 M-99.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
S$6.48 B-7.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$41.35 B 489.88%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
S$22.04 B 214.51%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel